Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancer
Xiuli Zhang, S. Peter Goedegebuure, Nancy B. Myers, Tammi Vickery, Michael D. McLellan, Feng Gao, Mark A. Sturmoski, Michael Y. Chen, Samuel W. Kim, Ina Chen, Jesse T Davidson 4th, Narendra V. Sankpal, Jasreet Hundal, Lijin Li, Stephanie Myles, Rama Suresh, Cynthia X. Ma, Ademuyiwa Foluso, Andrea Wang-Gillam, Sherri Davies, Ian Hagemann, Elaine R. Mardis, Malachi Griffith, Christopher A. Miller, Ted H. Hansen, Timothy P. Fleming, Robert D. Schreiber, William E. Gillanders
medRxiv 2021.11.19.21266466; doi: https://doi.org/10.1101/2021.11.19.21266466